Biotech Values

[DewDiligence]

The TID data seem better here then the BID, though I am not sure if they are stat sig.

As was the case with BG-12 vs Copaxone, the CONFIRM study did not perform (and never intended to perform) a statistical comparison of TID vs BID dosing.

Had a TID vs BID comparison been made, it’s clear that the result would have been non-statsig for superiority; the result of such a test for non-inferiority would have depended on the definition of the non-inferiority margin.